We have set up our new Discord server! Share your feedback and find like-minded people! Join our Discord

Ticker
GERN

Price
1.24
Stock movement up
+0.01 (0.81%)
Company name
Geron Corporation
Exchange
(NASDAQ
,
Currency
USD
)
Sector
Healthcare >
Biotechnology
Market cap
791.14M
Ent value
841.22M
Price/Sales
26.84
Price/Book
2.71
Div yield
-
Div growth
-
Growth years
-
FCF payout
-
Trailing P/E
-
Forward P/E
-
PEG
-
EPS growth
16.08%
1 year return
-70.62%
3 year return
-
5 year return
-
10 year return
-
Last updated: 2025-10-30

DIVIDENDS

GERN does not pay dividends or no data was received

iO Charts is a Seeking Alpha partner

iO Charts is a Seeking Alpha partner

VALUATION

Valuation Ratios

Loading...
Valuation Ratios data
Trailing P/E-
Price to OCF-
Price to FCF-
Price to EBITDA-
EV to EBITDA-

Valuation (Sales/Book Value)

Loading...
Valuation (Sales/Book Value) data
Price to Sales26.84
Price to Book2.71
EV to Sales28.54

iO Charts is a Seeking Alpha partner

FINANCIALS

Per share

Loading...
Per share data
Current share count638.02M
EPS (TTM)-
FCF per share (TTM)-

Income statement

Loading...
Income statement data
Revenue (TTM)-
Gross profit (TTM)-
Operating income (TTM)-
Net income (TTM)-
EPS (TTM)-
EPS (1y forward)-0.07

Margins

Loading...
Margins data
Gross margin (TTM)-
Operating margin (TTM)-
Profit margin (TTM)-

Balance Sheet

Loading...
Please create a free account or log in to access this chart
Balance Sheet data
Cash79.99M
Net receivables0.00
Total current assets522.34M
Goodwill0.00
Intangible assets0.00
Property, plant and equipment0.00
Total assets567.38M
Accounts payable0.00
Short/Current long term debt0.00
Total current liabilities87.71M
Total liabilities318.68M
Shareholder's equity0.00
Net tangible assets0.00

Cash flow

Loading...
Please create a free account or log in to access this chart
Cash flow data
Operating cash flow (TTM)-
Capital expenditures (TTM)-
Free cash flow (TTM)-
Dividends paid (TTM)-

Financial returns

Loading...
Please create a free account or log in to access this chart
Financial returns data
Return on Equity-
Return on Assets-
Return on Invested Capital-
Cash Return on Invested Capital-

iO Charts is a Seeking Alpha partner

iO Charts is a Seeking Alpha partner

STOCK INFORMATION

Stock chart

Loading...
Stock price data
Open1.23
Daily high1.28
Daily low1.22
Daily Volume3.64M
All-time high65.99
1y analyst estimate3.50
Beta0.56
EPS (TTM)-
Dividend per share0.00
Ex-div date-
Next earnings date-

Downside potential

Loading...
Downside potential data
GERNS&P500
Current price drop from All-time high-98.12%-1.10%
Highest price drop-98.33%-19.00%
Date of highest drop30 Jul 20258 Apr 2025
Avg drop from high-96.71%-2.76%
Avg time to new high-5 days
Max time to new high266 days89 days
COMPANY DETAILS
GERN (Geron Corporation) company logo
Marketcap
791.14M
Marketcap category
Small-cap
Description
Geron Corporation, a commercial-stage biopharmaceutical company, focuses on the development of therapeutics products for oncology. It offers RYTELO a telomerase inhibitor for the treatment f adult patients with low- to intermediate-1 risk myelodysplastic syndromes with transfusion-dependent anemia. The company was incorporated in 1990 and is headquartered in Foster City, California.
Employees
229
Investor relations
-
SEC filings
CEO
John A. Scarlett
Country
USA
City
Menlo Park
Stock type
Common stock
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...

iO Charts is a Seeking Alpha partner

iO Charts is a Seeking Alpha partner

UNDERSTAND THE BUSINESS
Loading...